Sean Morris

Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA.

The Medical Device Manufacturers Association operates as a trade association. The private company is based in Washington. The American company was founded by Thomas C. Thompson.

Pulse Therapeutics, Inc. provides medical devices to destroy blood clots. Its devices help in treating the stroke, heart disease and other conditions. Its products include MED System which helps in dissolve blood clots. The company was founded by Francis M. Creighton and Rogers Ritter in 2008 and is headquartered in St. Louis, Mo.

Euphrates Vascular, Inc. provides medical devices. It offers treatment addressing vascular occlusions related to vascular disease. The company is headquartered in St. Louis, MO.

Part of Surmodics, Inc., Vetex Medical Ltd. is a medical company based in Galway, Ireland. The Irish company's first innovation is the Revene thrombectomy catheter, which is specifically engineered for the treatment of venous disease. The catheter is 510(k) cleared by the FDA for mechanical de-clotting and controlled and selective infusion of physician-specified fluids, including thrombolytics, in the peripheral vasculature. The company was founded by Mark Bruzzi, who has been the CEO since incorporation. Vetex Medical was acquired by SurModics MD LLC on July 06, 2021 for $59.78 million.

Corvion, Inc. is a pre-clinical stage medical device company that focuses on bringing fully implanted heart assist technology to the worldwide market for mechanical circulatory support. The company is based in Webster, TX. The company aims to improve patient outcomes and quality of life by developing a highly efficient implantable rotary blood pump that is three times more efficient than competitors, coupled with a robust and flexible transcutaneous charging technology. Corvion offers an option for end-stage heart failure that gives back freedom and no longer limits the quality of life. The company was founded by Greg S. Aber, who has been the CEO since incorporation.